PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Cancer. Author manuscript; available in PMC 2014 April 1.
Published in final edited form as:
Published online 2012 December 7. doi:  10.1002/cncr.27896
PMCID: PMC3604037
NIHMSID: NIHMS416404

Risk of developing invasive breast cancer in Hispanic women: A look across Hispanic subgroups

Matthew P. Banegas, PhD, MPH,1,2,3,* Mei Leng, MS,4 Barry I. Graubard, PhD,5 and Leo S. Morales, MD, PhD, MPH1,2,6

Abstract

Background

Current evidence on breast cancer among US Hispanic women indicates a significant public health threat, although few studies assess the heterogeneity in breast cancer risk among Hispanics of different origin.

Methods

The 2000 and 2005 National Health Interview Survey (NHIS) Cancer Control Modules were used to examine the Breast Cancer Risk Assessment Tool (BCRAT) 5-year and lifetime risk of invasive breast cancer among Mexican/Mexican-American, Puerto Rican, Cuban/Cuban-American, Dominican (Republic), Central/South American, Other Hispanic and non-Hispanic white (NHW) women aged 35-84 years. Multiple linear regression models were used to compare the BCRAT 5-year and lifetime breast cancer risk between: i) Hispanics and NHWs and ii) Hispanic subgroups.

Results

Hispanics had significantly lower mean BCRAT 5-year and lifetime breast cancer risk compared to NHWs (p<0.001). Among Hispanic subgroups, Cuban/Cuban-Americans had a higher BCRAT 5-year risk (p<0.05), while Dominicans had a higher lifetime risk (p<0.001), compared to Mexican/Mexican-American women. Approximately, 2.6% of Hispanic women were at high-risk for breast cancer (BCRAT 5-year risk ≥1.67%), ranging from 1.0% of Central/South Americans to 3.7% of Puerto Ricans; few Hispanics (0.2%) had a lifetime risk ≥20.0%.

Conclusions

Our findings indicate that Hispanics had significantly lower risk of breast cancer, compared to NHWs, though BCRAT risk significantly differed between specific Hispanic subgroups. We provide estimates of the number of US Hispanic women, from six subgroups, who would be eligible for prophylactic breast cancer chemoprevention. Future studies should further investigate the heterogeneity in breast cancer risk and risk factors between Hispanic women of different origins.

Keywords: Breast cancer, Risk assessment, Hispanic/Latino, BCRAT

INTRODUCTION

Breast cancer is a significant public health threat to Hispanic women in the United States (US), as it represents the most frequently diagnosed cancer and leading cause of cancer-related death in this population1. Although recent trends show declining incidence of breast cancer among US women, breast cancer incidence has declined at a slower rate for US Hispanic women2; furthermore, these findings are consistent across stages of diagnosis, as the rate at which large breast cancer tumors are diagnosed among Hispanic women has not significantly declined3. Despite having a low incidence rate of breast cancer, Hispanic women are more likely to present with advanced breast cancer at diagnosis4, 5 and more likely to die from breast cancer compared non-Hispanic white women6.

Although these data reflect the burden of breast cancer among Hispanic women as a whole, it is also important to understand the diversity of this population and the extent to which the risk of breast cancer varies between Hispanic women of different national origins and backgrounds. US Hispanics women are characterized by differences in genetic ancestry, behavioral and lifestyle practices, which may lead to differences in the risk of developing breast cancer2. However, the heterogeneity in breast cancer risk among women in different Hispanic subgroups has not been well-defined.

To address this gap, our objective was to assess the distribution of breast cancer risk among Hispanic women from six subgroups: Mexican/Mexican-American, Puerto Rican, Cuban/Cuban-American, Dominican (Republic), Central/South American, and Other Hispanic. Using data from the 2000 and 2005 National Health Interview Survey (NHIS) Cancer Control Modules, we assessed the 5-year and lifetime risk of developing invasive breast cancer among US Hispanic (n=3,386) and non-Hispanic white (n=16,131) women, based on the National Cancer Institute (NCI) Breast Cancer Risk Assessment Tool (BCRAT). Evaluating breast cancer risk among different Hispanic subgroups has the potential to improve our understanding of the impact of breast cancer in this diverse population, and to identify those women from specific Hispanic subgroup who could benefit from breast cancer risk reduction strategies.

METHODS

Information about the study design, data source, and study population has been previously described in detail7. In brief, the NHIS is an annual, cross-sectional household survey that obtains information on the health of the civilian, non-institutionalized population residing in the United States8. The NHIS is a multistage cluster probability sample survey design, and oversamples both Hispanic and Black persons. Further, the NHIS core questionnaire is comprised of four components: household, family, sample adult, and sample child, with additional supplement questionnaires on specific topics, including: cancer control. The Cancer Control Module (CCM), designed and funded by the National Cancer Institute (NCI), was administered in 2000 and 2005 and it collected information on diet and nutrition, physical activity, tobacco usage, cancer screening, genetic testing, family history and other risk factors related to cancer. The 2000 and 2005 NHIS CCM collected data from one randomly sampled adult 18 years and older, from each sampled family and household, resulting in 32,374 and 31,321 sampled adults, respectively. For this study, we analyzed data on Hispanic (n=3,386) and non-Hispanic white females (n=16,131) aged 35-84 years, with no history of breast cancer or mastectomy (unilateral or bilateral), who completed the CCM module.

Key Measures

Absolute risk of developing breast cancer

Absolute risk is defined as the probability that a person with a given set of risk factors and free of the disease of interest at age x (e.g. age 40 years old), will develop disease before a subsequent age x+y (e.g. age 45 years old), where y is the time interval over which risk is projected9 (e.g. 5 years). The NCI Breast Cancer Risk Assessment Tool10,11 (http://www.cancer.gov/bcrisktool/) estimates a woman’s absolute risk of developing invasive breast cancer over a specific time period based on age, age at first live birth, age at menarche, number of first-degree relatives with breast cancer, number of breast biopsies, and presence of atypical hyperplasia. Information on atypical hyperplasia was unavailable in the NHIS. When information on a particular risk factor is missing, BCRAT imputes the lowest category of risk. We used the BCRAT to estimate participants’ absolute risk of invasive breast cancer over two time periods: i) 5-year risk: from age at interview to the hypothetical age that a woman would attain if she survived 5 years from the date of the interview; and ii) lifetime risk: from age at interview to the hypothetical age that a woman would attain if she survived to age 90 years.

Hispanic origin

The 2000 and 2005 NHIS collected self-reported data on race and Hispanic origin (based on country of origin and ancestry), which we used to categorize women as non-Hispanic white or Hispanic. Hispanic women were further divided into six distinct subgroups: Mexican/Mexican-American, Cuban/Cuban-American, Puerto Rican, Dominican (Republic), Central or South American, Other Latin American/Other Spanish/Multiple Hispanic (referred to as “Other Hispanic”).

Explanatory variables

We included several variables in the analyses that previous research indicates may be associated with the risk of developing breast cancer12-20. Sociodemographic variables included marital status (married/living with intimate partner, other), education (less than high school graduate, high school graduate/GED, more than high school), and federal poverty level (<100%, 100-200%, ≥200%). Two variables were included as proxies for access to health care: usual source of care (yes, no) and insurance status (private, public, uninsured). We also included information on county of birth (US born, foreign born), years in the US (<5 years, 5-9 years, ≥10 years) and language most often spoken (mostly/only Spanish, Spanish/English about the same, mostly/only English), and body mass index (BMI<25 “normal”, BMI 25-30 “overweight”, BMI>30 “obese”).

Statistical Analyses

Data from the 2000 and 2005 NHIS were pooled for this analysis. To obtain U.S. population estimates, the observations were weighted by the sample weights for each year, which were summed and divided by two21. The stratified, multi-stage cluster complex sample design of the NHIS was accounted for when calculating standard error (SE) and 95% confidence intervals (CIs)21.

Descriptive statistics were used to assess participants’ baseline sociodemographic, access, acculturation and BMI characteristics. We estimated participants’ BCRAT five-year and lifetime risk estimates, and corresponding 95% CIs as previously described10, 11. Statistical methods appropriate for complex samples were used to compare the distribution of descriptive variables between non-Hispanic white and Hispanic women, as well as between Hispanic subgroups, included t-test, chi-square test, and Wald’s F-test.

Multiple linear regression models were then estimated for both the five-year and lifetime absolute breast cancer risk estimates, separately, controlling for the explanatory variables. For each risk estimate, two different comparisons were made: 1) between Hispanic vs. non-Hispanic Whites and 2) among Hispanic subgroups. A three step multiple imputation method, previously used in analysis of a US-based population health survey and described22, was used to impute poverty level since about 24% of the observations were missing these values. First, we estimated an ordinal logistic regression model for poverty level using marital status, education and Hispanic subgroup combined with country of birth/time in the US. Second, for each individual with missing poverty level data, we generated probability cut-points for each category of poverty level, based on regression model coefficients. Third, we drew a random number between zero and one from a uniform distribution and compared it to the probability cut-points in order to assign each individual to one category. Noteworthy, the National Center for Health Statistics (NCHS) also generated imputed income variables for both the 2000 and 2005 NHIS surveys23; although, we used the previously described method for this study.

Additionally, a stepwise approach to the regression models was employed, using four different models. Model 1 adjusted for marital status, age, education, federal poverty level; Model 2 adjusted for model 1 covariates plus usual source of care and insurance; Model 3 adjusted for model 2 covariates plus BMI; and Model 4 adjusted for model 3 covariates plus country of origin and years in the US. For the acculturation, a composite variable was generated that combined county of birth (US born, foreign born) and years in the US (<5 years, 5-9 years, ≥10 years). Bivariate analyses indicated that language most often spoken was not predictive of breast cancer risk and, accordingly, was dropped from the final regression analyses. All computations were conducted using SAS software version 9.2 (SAS Institute Inc, Cary, North Carolina) and SAS callable SUDAAN version 9.0 (RTI, Research Triangle Park, North Carolina).

RESULTS

Sociodemographic and breast cancer risk factors

Non-Hispanic white women had a significantly higher mean age compared to Hispanic women (54.3 years vs. 50.3 years, respectively, p<0.001) (Table 1). Overall, a significantly greater proportion of Hispanics were younger than age 12 years at initiation of menarche, younger at first live birth, had no family history of breast cancer, and had never received a breast biopsy compared to non-Hispanic white women. Hispanic women, overall, had a significantly higher proportion with less than a high school education (46.0%) and had a household income that was less than 100% of the federal poverty level (21.7%) compared to non-Hispanic whites (11.9% and 6.8%, respectively).

Table 1
Distribution of BCRAT risk factors and breast cancer outcomes

Among Hispanic subgroups, Cuban/Cuban-American women had the highest mean age, 56.5 years. A greater proportion of Mexican/Mexican-American (48.3%) and Other Hispanic women (86.5%) were born in the US, while Puerto Rican women had the greatest proportion that spoke only/mostly Spanish (27.4%). Puerto Rican (91.4%) and Other Hispanic (93.8%) women had the greatest proportion with a usual source of care, and Central/South American had the greatest proportion of uninsured women (52.8%). Mexican/Mexican-American (36.4%) and Puerto Ricans (36.7%) had the greatest proportion of obese women among Hispanic subgroups.

Absolute risk of developing breast cancer

Table 2 presents the mean 5-year and lifetime BCRAT absolute risk estimates of study participants. These results indicate that, for Hispanic women in our study, on average, the probability of developing invasive breast cancer over the next five years was 0.64% and over their lifetime was 5.88%, which is significantly lower than for non-Hispanic whites (1.24% and 8.63%, respectively, p<0.001). Among Hispanic women, Cuban/Cuban-American and Other Hispanic women had a significantly higher mean BCRAT 5-year absolute risk compared to Mexican/Mexican-American women (p<0.001). Dominican and Central/South American women had a significantly higher mean BCRAT lifetime absolute risk compared to Mexican/Mexican-American women (p<0.001).

Table 2
Mean BCRAT five-year and lifetime absolute risk estimates by Hispanic subgroup

A significantly lower proportion of Hispanic women were at high risk of breast cancer compared to non-Hispanic white women (p<0.001, Table 3), based on both the BCRAT 5-year and lifetime risk estimate (e.g. the threshold values for identifying women at high-risk, as defined by ASCO and NCCN, of ≥1.67% 5-year risk of invasive breast cancer and ≥20% lifetime risk of invasive breast cancer). Approximately 2.6% of all Hispanic women had BCRAT 5-year absolute risk ≥1.67% and only 0.2% had a lifetime absolute risk ≥20.0%. Central/South American women had a significantly lower proportion of women at high risk of breast cancer (1.0%) compared to Mexican/Mexican-American women (2.7%, p<0.001). Among Hispanic subgroups, few women had a BCRAT lifetime absolute risk ≥20.0%, with only 0.4% of Other Hispanic women and 0.3% of Mexican/Mexican-American women meeting this high-risk threshold.

Table 3
Estimates of the total number of women at high risk of breast cancer based on BCRAT five-year and lifetime absolute risk estimates

Multivariate regression analyses

Table 4 summarizes the results of the multivariate regression models, indicating that Hispanic women had significantly lower 5-year and lifetime absolute risk of developing breast cancer, based on the BCRAT, compared to non-Hispanic whites (p<0.001). Hispanic women’s mean 5-year absolute risk of invasive breast cancer was consistently lower than for non-Hispanic white women (by an difference of 0.4 percentage points; p<0.001), while the mean lifetime absolute risk of invasive breast cancer for Hispanics was approximately 2.8 percentage points lower than for non-Hispanic white women (p<0.001).

Table 4
Results of multivariate regression analyses of BCRAT 5-year and lifetime absolute risk of breast cancer by Hispanic subgroup

In regard to Hispanics, Cuban/Cuban-American women’s mean 5-year absolute risk of breast cancer was higher than the risk for Mexican/Mexican-American women (p<0.05). No other differences in BCRAT 5-year absolute risk were observed among Hispanic subgroups, when compared to Mexican/Mexican-American women. In assessing lifetime absolute risk of breast cancer, Dominican women’s mean risk was significantly higher than the mean risk for Mexican/Mexican-American women, and remained significant after controlling for all covariates (p<0.001). There were no other differences observed in lifetime absolute risk when comparing other Hispanic subgroups to Mexican/Mexican-American women.

Comparing all Hispanics to non-Hispanic whites, age, education, poverty level, insurance status and BMI were all significantly associated with women’s 5-year absolute risk of breast cancer (results not shown). In particular, increased age, having public health insurance and being overweight/obese were all associated with significant increases in 5-year absolute risk. Similar trends were observed for lifetime absolute risk of breast cancer, although increased age was associated with a significantly lower lifetime absolute risk of breast cancer. For comparisons among Hispanic subgroups, age, marital status, education, poverty level, insurance status and years in the US were significantly associated with 5-year absolute risk of breast cancer (results not shown). Specifically, women of the same Hispanic subgroup who had lived in the US for less than 5 years, had a significantly lower 5-year absolute risk of breast cancer compared to those women born in the US (p<0.05), controlling for all other covariates. This association was not observed for lifetime risk of breast cancer.

DISCUSSION

Building on current literature, the present study was a broad assessment of the absolute risk of developing breast cancer among different subgroups of Hispanic women. Our findings indicate that, overall, Hispanic women’s 5-year and lifetime absolute risk of developing invasive breast cancer, based on the BCRAT, were significantly lower compared to non-Hispanic white women. Among Hispanic subgroups, Cuban/Cuban-American women had a greater BCRAT 5-year absolute risk of developing invasive breast cancer, while Dominican women had a greater BCRAT lifetime absolute risk of invasive breast cancer. Factors including age, education, health insurance, usual source of care, poverty level, and length of residence in the US were associated with differences in breast cancer risk among Hispanic subgroups. Furthermore, the proportion of Hispanic women who may be eligible for breast cancer risk reduction strategies such as prophylactic tamoxifen and raloxifene use, based on the American Society of Clinical Oncology (ASCO) and National Comprehensive Cancer Network (NCCN) guidelines, ranges from about 1% of Central/South American women to 4% of Puerto Rican women.

Consistent with previous findings24, we found that Hispanic women have a significantly lower 5-year and lifetime absolute risk of developing invasive breast cancer, based on the BCRAT. Further, the magnitude by which Hispanic women’s breast cancer risk was lower than non-Hispanic whites remained significant, and relatively constant, even after multivariate adjustment for key risk factors. These findings suggest other factors, either unidentified and/or unmeasured in this analysis, may help explain the differences observed in BCRAT risk estimates between Hispanic and non-Hispanic white women.

Evidence on the risk of developing breast cancer risk among Hispanics has highlighted differences between US and foreign-born women15, with results from the San Francisco Bay Area Women’s Breast Cancer Study showing that foreign-born Hispanic post-menopausal women had a significantly lower risk of breast cancer compared to their US-born counterparts. Our study expands on this by evaluating differences in risk by Hispanic subgroup, finding that, compared to Mexican/Mexican-American women, Cuban/Cuban-Americans had a significantly higher 5-year risk of breast cancer, whereas Dominicans had a significantly higher lifetime risk of breast cancer. Consequently, while BCRAT risk among other Hispanic subgroups did not differ, the increased risk among Cuban/Cuban-American and Dominican women may reflect other important underlying factors, such as genetic ancestry 25, that account for differences in BCRAT estimates of the risk of developing invasive breast cancer among these Hispanic subgroups.

Our finding of lower breast cancer risk in foreign-born Hispanic women, with less than five years of residence in the US, further strengthens the importance of birthplace, migration and length of residence in the US as factors associated with breast cancer risk among Hispanic women15, 26. Therefore, migration-related changes experienced by Hispanic women who move to the US, such as those to hormonal and lifestyle factors (i.e. weight gain or changes in diet), may have important ramifications on the risk of developing breast cancer.

Noteworthy, our study is among the first, if not only, to provide an estimate of the proportion and number of women from different Hispanic subgroups who may be eligible for prophylactic tamoxifen and raloxifene use. Both ASCO and NCCN recommend that patients who meet the high risk threshold of BCRAT 5-year risk ≥1.67% are eligible for, and may consider, counseling about propylactic tamoxifen or raloxifene to reduce the risk of developing invasive breast cancer in the future27, 28. Thus, as indicated by our findings, up to 2.7% of Mexican-American women (approximately 99,000 women) or 3.7% of Puerto Rican women (approximately 30,000 women), among others, may benefit from risk-reduction counseling to consider their options for preventing the onset of breast cancer.

In interpreting the results of this study it is important to acknowledge its strengths and limitations. The NHIS is a large, population-based study, which allowed us to explore US Hispanic women; however, our study was limited by small samples of women from certain Hispanic subgroups. Nevertheless, these findings build upon those studies of breast cancer risk among different subgroups of Hispanic women, adding considerably to the sparse literature documenting the heterogeneity of the Hispanic population. A possible limitation of this study is that the NHIS is a cross-sectional study and, therefore, we are not able to draw any causal inference on the relationship between breast cancer risk and the risk factors included in our analysis. Another limitation is the use of the NCI BCRAT to estimate breast cancer risk, which has been shown to underestimate risk among US Hispanic women29. Despite such underestimation, our findings represent a conservative estimate of breast cancer risk among Hispanic women and the number of women in each subgroup who could benefit from risk-reduction strategies.

In summary, our findings indicate that, based on the BCRAT, Hispanic women have a significantly lower absolute risk of developing invasive breast cancer, compared to non-Hispanic white women; furthermore, we highlight differences in the BCRAT risk among women in different Hispanic subgroups. While country of origin and length of residence were significantly associated with BCRAT risk estimates in our study sample, it is imperative to further investigate how Hispanic ancestry and migration impact women’s risk factors for developing breast cancer. Lastly, we provide national estimates of the number of Hispanic women, from six key subgroups, who would be eligible for counseling to consider risk reduction by prophylactic breast cancer chemoprevention, as recommended by ASCO and NCCN. Future studies are warranted that further investigate the impact of breast cancer among Hispanics of different ancestry, as well as other important breast cancer risk factors, such as history of cancer in second and higher-degree relatives in this population.

Acknowledgements

The authors would like to thank Dr. Mitchell Gail and Dr. Jeremy Steeves for their input on the manuscript. M.P.Banegas conducted this work while at the University of Washington and Fred Hutchinson Cancer Research Center and was supported, in part, by the National Cancer Institute Biobehavioral Cancer Prevention and Control Training Program (R25CA092408) at the University of Washington and the National Cancer Institute Center for Hispanic Health Promotion Training Program (1U54CA153502-01) at the Fred Hutchinson Cancer Research Center.

Footnotes

Competing Interests: None declared.

References

1. American Cancer Society (ACS) Cancer facts and figures for Hispanic/Latinos 2009-2011. ACS; 2009.
2. Haile RW, John EM, Levine AJ, Cortessis VK, Unger JB, Gonzales M, et al. A review of cancer in U.S. Hispanic populations. Cancer Prev Res (Phila) 2012;5(2):150–63. [PubMed]
3. Hausauer AK, Keegan TH, Chang ET, Clarke CA. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype. Breast Cancer Res. 2007;9(6):R90. [PMC free article] [PubMed]
4. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163(1):49–56. [PubMed]
5. Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Barbash RB, Strzelczyk J, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541–53. [PubMed]
6. American Cancer Society Breast cancer facts and figures, 2011-2012. American Cancer Society, Inc.;
7. Graubard BI, Freedman AN, Gail MH. Five-year and lifetime risk of breast cancer among U.S. subpopulations: implications for magnetic resonance imaging screening. Cancer Epidemiol Biomarkers Prev. 2010;19(10):2430–6. [PMC free article] [PubMed]
8. Botman SL, Moore TF, Moriarity CL, Parsons Vl. Design and estimation for the National Health Interview Survey, 1995-2004. Vital and Health Statistics. 2000;2(130)
9. Gail MH. Personalized estimates of breast cancer risk in clinical practice and public health. Stat Med. 2011;30(10):1090–104. [PMC free article] [PubMed]
10. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879–86. [PubMed]
11. Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999;91(18):1541–8. [PubMed]
12. Thomas DB, Karagas MR. Migrant studies. 2nd ed Oxford University Press; New York, NY: 1996. pp. 236–254.
13. Parkin DM, Khlat M. Studies of cancer in migrants: rationale and methodology. Eur J Cancer. 1996;32A(5):761–71. [PubMed]
14. McCredie M. Cancer epidemiology in migrant populations. Recent Results Cancer Res. 1998;154:298–305. [PubMed]
15. John EM, Phipps AI, Davis A, Koo J. Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prev. 2005;14(12):2905–13. [PubMed]
16. John EM, Sangaramoorthy M, Phipps AI, Koo J, Horn-Ross PL. Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer study. Am J Epidemiol. 2010;173(2):201–16. [PMC free article] [PubMed]
17. Yin D, Morris C, Allen M, Cress R, Bates J, Liu L. Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups? Cancer Causes Control. 2010;21(10):1721–30. [PMC free article] [PubMed]
18. Rodriguez MA, Ward LM, Perez-Stable EJ. Breast and cervical cancer screening: impact of health insurance status, ethnicity, and nativity of Latinas. Ann Fam Med. 2005;3(3):235–41. [PubMed]
19. Lewis C, Ventura S. Birth and fertility rates by education: 1980 and 1985. Vital Health Stat. 1990;21(49):1–40. [PubMed]
20. Baquet CR, Commiskey P. Socioeconomic factors and breast carcinoma in multicultural women. Cancer. 2000;88(5 Suppl):1256–64. [PubMed]
21. Korn EL, Graubard BI. Analysis of Health Surveys. Jon Wiley & Sons; New York (NY): 1999. pp. 22–8.pp. 64–8.
22. Flores YN, Yee HF, Jr., Leng M, Escarce JJ, Bastani R, Salmeron J, et al. Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol. 2008;103(9):2231–8. [PubMed]
23. Division of Health Interview Statistics, National Center for Health Statistics. Multiple Imputation of Family Income and Personal Earnings in the National Health Interview Survey: Methods and Examples. Available from URL: http://www.cdc.gov/nchs/data/nhis/tecdoc_2010.pdf.
24. Kurian AW, Fish K, Shema SJ, Clarke CA. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 2010;12(6):R99. [PMC free article] [PubMed]
25. Ziv E, John EM, Choudhry S, Kho J, Lorizio W, Perez-Stable EJ, et al. Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1878–85. [PubMed]
26. Pike MC, Kolonel LN, Henderson BE, Wilkens LR, Hankin JH, Feigelson HS, et al. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev. 2002;11(9):795–800. [PubMed]
27. Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, et al. Breast cancer risk reduction. J Natl Compr Canc Netw. 2010;8(10):1112–46. [PubMed]
28. Visvanathan K, Lippman SM, Hurley P, Temin S. American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. Gynecol Oncol. 2009;115(1):132–4. [PubMed]
29. Banegas MP, Gail MH, Lacroix A, Thompson B, Martinez ME, Wactawski-Wende J, et al. Evaluating breast cancer risk projections for Hispanic women. Breast Cancer Res Treat. 2012;132(1):347–53. [PMC free article] [PubMed]